416
Participants
Start Date
June 30, 2015
Primary Completion Date
November 30, 2017
Study Completion Date
November 30, 2017
VPM1002
Tuberculosis vaccine
BCG
commercially available live vaccine BCG
VPM1002(Hyg+)
Tuberculosis vaccine
Children's Infectious Diseases Clinical Research Unit, Tygerberg Hospital, Cape Town
Desmond Tutu TB Centre, Cape Town
South African Tuberculosis Vaccine Initiative, Cape Town
The Respiratory and Meningeal Pathogens Reserach Unit, Johannesburg
Serum Life Science Europe GmbH
INDUSTRY
Triclinium Clinical Trial Project Management
UNKNOWN
Children's Infectious Diseases Clinical Research Unit (KID-CRU)
UNKNOWN
Desmond Tutu TB Centre
OTHER
The Respiratory and Meningeal Pathogens Research Unit (RMPRU)
UNKNOWN
South African Tuberculosis Vaccine Initiative
OTHER
University of Stellenbosch
OTHER
Serum Institute of India Pvt. Ltd.
INDUSTRY